PMID- 25812086 OWN - NLM STAT- MEDLINE DCOM- 20160113 LR - 20220408 IS - 1935-2735 (Electronic) IS - 1935-2727 (Print) IS - 1935-2727 (Linking) VI - 9 IP - 3 DP - 2015 Mar TI - Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria. PG - e0003633 LID - 10.1371/journal.pntd.0003633 [doi] LID - e0003633 AB - BACKGROUND: Loiasis is currently receiving attention as a disease of public health importance because of the possibility of increased risk of developing neurologic serious adverse event following mass ivermectin treatment against onchocerciasis in individual co-infected with Onchocerca volvulus and Loa loa. METHODOLOGY/PRINCIPAL FINDINGS: Rapid assessment procedure for loiasis (RAPLOA) was conducted in 12 communities covering the 3 senatorial districts of Osun State, Nigeria. A total of 960 people were interviewed for history of eye worm using the WHO guidelines for rapid assessment. The survey confirmed the presence of loiasis in all the 12 communities with 4 in Osun East/Ife south senatorial district being at high risk with a prevalence of over 40%. Based on the RAPLOA results, communities within Osun East/Ife south senatorial district were selected for microfilaraemic assessment of L. loa and O. volvulus. A total of 1115 and 1091 individuals were screened for L. loa and O. volvulus microfilaria worms respectively. 160 (14.3%) had L. loa microfilaria detected in their blood with 8 (5.0%) individuals having L. loa loads above 8000 mf/ml. 166 (15.2%) subjects had O. volvulus microfilaria (range 4-504 mf/ml) detected in their skin snip. 30 (2.69%) subjects were co-infected with both L. loa and O. volvulus. There was a significant variation in the prevalence (2.1% to 33.3%) of onchocerciasis in the communities studied (p = 0.001). Five (41.7%) of the studied communities had a prevalence that is equal to or greater than 20%. CONCLUSIONS/SIGNIFICANCE: Low prevalence of onchocerciasis and loiasis co-infection in this study suggests that loiasis may not pose a serious epidemiological threat to the continuous distribution and sustainability of ivermectin for the treatment of onchocerciasis. Evaluation of the interruption of onchocerciasis transmissions in this region using all the indicators set forth by WHO is therefore suggested. FAU - Ojurongbe, Olusola AU - Ojurongbe O AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Akindele, Akeem Abiodun AU - Akindele AA AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria; Department of Community Medicine, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Adeleke, Monsuru Adebayo AU - Adeleke MA AD - Department of Biological Sciences, Osun State University, Osogbo, Nigeria. FAU - Oyedeji, Matthew Oyebode AU - Oyedeji MO AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Adedokun, Samuel Adeyinka AU - Adedokun SA AD - Department of Community Medicine, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Ojo, Josephine Folashade AU - Ojo JF AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Akinleye, Callistus Adewale AU - Akinleye CA AD - Department of Community Medicine, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Bolaji, Oloyede Samuel AU - Bolaji OS AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Adefioye, Olusegun Adelowo AU - Adefioye OA AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. FAU - Adeyeba, Oluwaseyi Adegboyega AU - Adeyeba OA AD - Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150326 PL - United States TA - PLoS Negl Trop Dis JT - PLoS neglected tropical diseases JID - 101291488 RN - 0 (Filaricides) RN - 70288-86-7 (Ivermectin) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Animals MH - Child MH - Child, Preschool MH - Coinfection/diagnosis/drug therapy/epidemiology MH - Endemic Diseases MH - Female MH - Filaricides/adverse effects/*therapeutic use MH - Humans MH - Ivermectin/therapeutic use MH - Loa/isolation & purification MH - Loiasis/diagnosis/drug therapy/*epidemiology MH - Male MH - Middle Aged MH - Nigeria/epidemiology MH - Onchocerca volvulus/isolation & purification MH - Onchocerciasis/diagnosis/drug therapy/*epidemiology MH - Prevalence MH - Public Health MH - Rainforest MH - Young Adult PMC - PMC4374772 COIS- The authors have declared that no competing interests exist. EDAT- 2015/03/27 06:00 MHDA- 2016/01/14 06:00 PMCR- 2015/03/26 CRDT- 2015/03/27 06:00 PHST- 2014/06/19 00:00 [received] PHST- 2015/02/20 00:00 [accepted] PHST- 2015/03/27 06:00 [entrez] PHST- 2015/03/27 06:00 [pubmed] PHST- 2016/01/14 06:00 [medline] PHST- 2015/03/26 00:00 [pmc-release] AID - PNTD-D-14-01037 [pii] AID - 10.1371/journal.pntd.0003633 [doi] PST - epublish SO - PLoS Negl Trop Dis. 2015 Mar 26;9(3):e0003633. doi: 10.1371/journal.pntd.0003633. eCollection 2015 Mar.